Jonathan Karn
Affiliations: | Molecular Biology and Microbiology | Case Western Reserve University, Cleveland Heights, OH, United States |
Area:
Molecular BiologyGoogle:
"Jonathan Karn"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kaur H, Minchella P, Alvarez-Carbonell D, et al. (2023) Contemporary Antiretroviral Therapy Dysregulates Iron Transport and Augments Mitochondrial Dysfunction in HIV-Infected Human Microglia and Neural-Lineage Cells. International Journal of Molecular Sciences. 24 |
| Sanders-Beer BE, Archin NM, Brumme ZL, et al. (2023) Current HIV/SIV Reservoir Assays for Preclinical and Clinical Applications: Recommendations from the Experts 2022 NIAID Workshop Summary. Aids Research and Human Retroviruses |
| Rheinberger M, Costa AL, Kampmann M, et al. (2023) Genomic profiling of HIV-1 integration in microglia cells links viral integration to the topologically associated domains. Cell Reports. 42: 112110 |
| Mbonye U, Kizito F, Karn J. (2022) New insights into transcription elongation control of HIV-1 latency and rebound. Trends in Immunology |
| Wietgrefe SW, Duan L, Anderson J, et al. (2022) Detecting Sources of Immune Activation and Viral Rebound in HIV Infection. Journal of Virology. e0088522 |
| Sreeram S, Ye F, Garcia-Mesa Y, et al. (2022) The potential role of HIV-1 latency in promoting neuroinflammation and HIV-1-associated neurocognitive disorder. Trends in Immunology |
| Ye F, Alvarez-Carbonell D, Nguyen K, et al. (2022) Recruitment of the CoREST transcription repressor complexes by Nerve Growth factor IB-like receptor (Nurr1/NR4A2) mediates silencing of HIV in microglial cells. Plos Pathogens. 18: e1010110 |
| Scully EP, Aga E, Tsibris A, et al. (2022) Impact of Tamoxifen on Vorinostat-Induced HIV Expression in Women on Antiretroviral Therapy (ACTG A5366:The MOXIE trial). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Miller JS, Davis ZB, Helgeson E, et al. (2022) Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial. Nature Medicine |
| Joussef-Piña S, Nankya I, Nalukwago S, et al. (2022) Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda. Retrovirology. 19: 1 |